Maryland House Bill 1256 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 8 2021 - 25% progression, died in chamber
Action: 2021-04-05 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]

Requiring the Maryland Department of Health, by January 1, 2023, to develop gene sequence and customer screening guidelines for gene synthesis providers and manufacturers of gene synthesis equipment that include certain requirements; requiring the Department to develop a process to certify that gene synthesis providers and manufacturers of gene synthesis equipment are in compliance with the guidelines; requiring, on or after January 1, 2024, the Department to certify certain gene synthesis providers and equipment manufacturers; etc.

Maryland Department of Health – Gene Synthesis Providers and Manufacturers of Gene Synthesis Equipment – Certification

Sen. Karen Lewis Young [D]

Date	Chamber	Action
2021-04-05	House	Withdrawn by Sponsor
2021-02-11	House	Hearing 3/09 at 1:30 p.m.
2021-02-08	House	First Reading Health and Government Operations

Chapter	Article	Section	Citation Type	Statute Text
Health - General	17	801	(n/a)	See Bill Text
Health - General	17	802	(n/a)	See Bill Text
Health - General	17	803	(n/a)	See Bill Text
Health - General	17	804	(n/a)	See Bill Text
Health - General	17	805	(n/a)	See Bill Text
Health - General	17	806	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1256?ys=2021RS
Text	https://mgaleg.maryland.gov/2021RS/bills/hb/hb1256f.pdf
Supplement	https://mgaleg.maryland.gov/2021RS/votes_comm/hb1256_hgo.pdf